Type 2 diabetes. Type 1 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetes Age over 18 years Body mass index 18.5–30 kg / m Willing to participate in the study
Exclusion criteria
Exclusion criteria: Type 1 diabetes Pregnancy or other specific types of diabetes Insulin therapy over the past three months Having serious gastrointestinal (GI) diseases including stomach ulcers and gastrointestinal bleeding Having an autoimmune disease Osteoarthritis Chronic uremia Use of drugs that affect the symptoms of neuropathy such as antidepressants and anticonvulsants Allergy to Lemongrass
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical signs of neuropathy. Timepoint: Beginning and end of three months of treatment. Method of measurement: Physical examination.;Electrodiagnostic findings. Timepoint: Beginning and end of three months of treatment. Method of measurement: An electromyographic device will be used for this purpose.;Laboratory findings including Fasting blood sugar and hemoglobin A1c. Timepoint: Beginning and end of three months of treatment. Method of measurement: Based on laboratory evaluation of patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences